These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32760423)

  • 1. Predicting Cancer Tissue-of-Origin by a Machine Learning Method Using DNA Somatic Mutation Data.
    Liu X; Li L; Peng L; Wang B; Lang J; Lu Q; Zhang X; Sun Y; Tian G; Zhang H; Zhou L
    Front Genet; 2020; 11():674. PubMed ID: 32760423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating DNA Methylation, Gene Expression, Somatic Mutation, and Their Combinations in Inferring Tumor Tissue-of-Origin.
    Liu H; Qiu C; Wang B; Bing P; Tian G; Zhang X; Ma J; He B; Yang J
    Front Cell Dev Biol; 2021; 9():619330. PubMed ID: 34012960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A machine learning framework to trace tumor tissue-of-origin of 13 types of cancer based on DNA somatic mutation.
    He B; Dai C; Lang J; Bing P; Tian G; Wang B; Yang J
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165916. PubMed ID: 32771416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TOOme: A Novel Computational Framework to Infer Cancer Tissue-of-Origin by Integrating Both Gene Mutation and Expression.
    He B; Lang J; Wang B; Liu X; Lu Q; He J; Gao W; Bing P; Tian G; Yang J
    Front Bioeng Biotechnol; 2020; 8():394. PubMed ID: 32509741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
    Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
    EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep Learning-Based Identification of Tissue of Origin for Carcinomas of Unknown Primary Using MicroRNA Expression: Algorithm Development and Validation.
    Raghu A; Raghu A; Wise JF
    JMIR Bioinform Biotechnol; 2024 Jul; 5():e56538. PubMed ID: 39046787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features.
    Nguyen L; Van Hoeck A; Cuppen E
    Nat Commun; 2022 Jul; 13(1):4013. PubMed ID: 35817764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen.
    Marquard AM; Birkbak NJ; Thomas CE; Favero F; Krzystanek M; Lefebvre C; Ferté C; Jamal-Hanjani M; Wilson GA; Shafi S; Swanton C; André F; Szallasi Z; Eklund AC
    BMC Med Genomics; 2015 Oct; 8():58. PubMed ID: 26429708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary.
    Shen Y; Chu Q; Yin X; He Y; Bai P; Wang Y; Fang W; Timko MP; Fan L; Jiang W
    Brief Bioinform; 2021 Mar; 22(2):2106-2118. PubMed ID: 32266390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The practical utility of AI-assisted molecular profiling in the diagnosis and management of cancer of unknown primary: an updated review.
    Lorkowski SW; Dermawan JK; Rubin BP
    Virchows Arch; 2024 Feb; 484(2):369-375. PubMed ID: 37999736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying cancer tissue-of-origin by a novel machine learning method based on expression quantitative trait loci.
    Miao Y; Zhang X; Chen S; Zhou W; Xu D; Shi X; Li J; Tu J; Yuan X; Lv K; Tian G
    Front Oncol; 2022; 12():946552. PubMed ID: 36016607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue of origin prediction for cancer of unknown primary using a targeted methylation sequencing panel.
    Sun M; Xu B; Chen C; Zhu Y; Li X; Chen K
    Clin Epigenetics; 2024 Feb; 16(1):25. PubMed ID: 38336771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers.
    Grewal JK; Tessier-Cloutier B; Jones M; Gakkhar S; Ma Y; Moore R; Mungall AJ; Zhao Y; Taylor MD; Gelmon K; Lim H; Renouf D; Laskin J; Marra M; Yip S; Jones SJM
    JAMA Netw Open; 2019 Apr; 2(4):e192597. PubMed ID: 31026023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel XGBoost Method to Identify Cancer Tissue-of-Origin Based on Copy Number Variations.
    Zhang Y; Feng T; Wang S; Dong R; Yang J; Su J; Wang B
    Front Genet; 2020; 11():585029. PubMed ID: 33329723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Tumor Tissue of Origin with RNA-Seq Data and Using Gradient Boosting Strategy.
    Li R; Liao B; Wang B; Dai C; Liang X; Tian G; Wu F
    Biomed Res Int; 2021; 2021():6653793. PubMed ID: 33681364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting cancer type from tumour DNA signatures.
    Soh KP; Szczurek E; Sakoparnig T; Beerenwinkel N
    Genome Med; 2017 Nov; 9(1):104. PubMed ID: 29183400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine Learning Approaches to Classify Primary and Metastatic Cancers Using Tissue of Origin-Based DNA Methylation Profiles.
    Modhukur V; Sharma S; Mondal M; Lawarde A; Kask K; Sharma R; Salumets A
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers.
    Deist TM; Dankers FJWM; Valdes G; Wijsman R; Hsu IC; Oberije C; Lustberg T; van Soest J; Hoebers F; Jochems A; El Naqa I; Wee L; Morin O; Raleigh DR; Bots W; Kaanders JH; Belderbos J; Kwint M; Solberg T; Monshouwer R; Bussink J; Dekker A; Lambin P
    Med Phys; 2018 Jul; 45(7):3449-3459. PubMed ID: 29763967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Machine Learning Method to Trace Cancer Primary Lesion Using Microarray-Based Gene Expression Data.
    Lu Q; Chen F; Li Q; Chen L; Tong L; Tian G; Zhou X
    Front Oncol; 2022; 12():832567. PubMed ID: 35530331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-cohort computational framework to trace tumor tissue-of-origin based on RNA sequencing.
    He B; Sun H; Bao M; Li H; He J; Tian G; Wang B
    Sci Rep; 2023 Sep; 13(1):15356. PubMed ID: 37717102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.